Recombinant Mouse M-CSF: Macrophage Workflows
2026-08-10
Build more reproducible macrophage, osteoclast, tumor-killing, and pulmonary fibrosis assays with a defined, tag-free mouse cytokine input. This guide connects M-CSF-driven cell preparation to the IGF2BP1–THBS1–TLR4 mechanism and provides practical dosing, controls, and troubleshooting strategies.
CFTRinh-172 Workflows for Epithelial Transport
2026-08-09
CFTRinh-172 provides a rapid, reversible way to verify whether epithelial ion transport depends on CFTR channel activity. This guide connects acute functional assays with surface-abundance studies, cystic fibrosis research, and preclinical models of secretory diarrhea.
EAGLE-1: Oral Gepotidacin for Gonorrhoea
2026-08-08
The phase 3 EAGLE-1 trial found that two oral doses of gepotidacin were non-inferior to intramuscular ceftriaxone plus oral azithromycin for microbiological eradication of uncomplicated urogenital gonorrhoea. The findings support gepotidacin as a potential oral option while emphasizing the importance of population, anatomical-site, resistance, and follow-up limitations.
LSKL, THBS1, and Oxidative Stress in PCOS
2026-08-07
The reference study identifies THBS1 as a mechanistic link between DHEA-associated granulosa-cell injury, oxidative stress, apoptosis, and impaired PI3K/AKT signaling in a rat model of polycystic ovary syndrome. Its evidence suggests that the THBS1 inhibitor LSKL can improve ovarian and cellular phenotypes, while also illustrating how ROS measurements should be interpreted alongside functional, histological, hormonal, and signaling data.
Sulfaphenazole: CYP2C9 Inhibitor for Advanced Vascular Resea
2026-08-07
Sulfaphenazole stands apart as a selective CYP2C9 inhibitor, enabling reproducible workflows in vascular, drug metabolism, and anti-infective research. Its dual role as a modulator of cytochrome P450 and a low-cytotoxicity antibacterial agent empowers experiments that bridge pharmacology and tissue recovery.
Ganoderma lucidum Polysaccharide Enhances mRNA-LNP Efficacy
2026-08-06
This study demonstrates that Ganoderma lucidum polysaccharide (GLP) can be used as a novel adjuvant to improve the performance of mRNA-loaded lipid nanoparticles (LNPs) by mitigating oxidative stress and increasing translation efficiency. The findings provide a mechanistic basis for safer and more effective mRNA delivery, with potential implications for vaccine and gene therapy development.
Methicillin Sodium Salt: Protocols and Pitfalls in MSSA Rese
2026-08-06
Methicillin sodium salt stands as the benchmark for modeling Staphylococcus aureus infection dynamics and quantifying cell wall synthesis inhibition in MSSA. This guide details rigorous workflows, data-backed troubleshooting, and how APExBIO’s high-purity product empowers reproducibility in antimicrobial susceptibility and resistance studies.
Levofloxacin: Applied Workflows for DNA Replication & Bone A
2026-08-05
Levofloxacin stands out as a synthetic fluoroquinolone antibiotic for dissecting bacterial DNA replication and bone-cartilage metabolism in research. This guide showcases optimized workflows, troubleshooting insights, and comparative advantages for leveraging Levofloxacin in cell-based and microbiological assays.
Annexin V-Cy5 Apoptosis Kit: Precision Detection in Lysosoma
2026-08-05
The Annexin V-Cy5 Apoptosis Kit streamlines apoptotic cell detection even in challenging neuroimmune settings, like reversible lysosomal stress in microglia. Its rapid, bright Cy5 workflow enables robust quantification by both flow cytometry and imaging, with protocol enhancements and troubleshooting strategies informed by recent zebrafish model studies.
GSH and GSSG Assay Kit: Precision Reduced Glutathione Detect
2026-08-04
Unlock high-sensitivity, dual-mode glutathione quantification with the GSH and GSSG Assay Kit. This powerful tool streamlines redox state analysis and troubleshooting, enabling advanced oxidative stress and immunometabolism research in challenging sample types.
Sodium Phosphate Dibasic: Precision Buffering for Aquatic As
2026-08-04
Sodium phosphate dibasic (Na2HPO4) delivers reproducible, high-fidelity pH stabilization in aquatic toxicity and molecular biology workflows. Learn how APExBIO’s high-purity product elevates buffer integrity, supports sensitive bioassays, and enables reliable, actionable environmental research.
Methicillin Sodium Salt: Mechanism, Benchmarks, and Laborato
2026-08-03
Methicillin sodium salt is a semi-synthetic penicillin antibiotic that inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins. It is effective for modeling methicillin-sensitive Staphylococcus aureus (MSSA) infections but is ineffective against MRSA strains expressing PBP2a. This article details its mechanism, verified laboratory benchmarks, and strategic applications in microbiological research.
Mianserin HCl: 5-HT2 Receptor Antagonist for Research Use
2026-08-03
Mianserin HCl is a tetracyclic antidepressant and selective 5-HT2 receptor antagonist with validated efficacy in depression and unique applications in antipathogenic research. It shows favorable tolerability and forms inclusion complexes that enhance cytotoxicity in vitro. This article provides a structured, evidence-backed dossier for research and protocol design.
CB-5083: A Potent p97 Inhibitor for Tumor Growth Suppression
2026-08-02
CB-5083 is a selective, orally bioavailable p97 inhibitor that disrupts protein homeostasis and induces apoptosis in cancer cells. This article reviews mechanistic details, benchmark data, and workflow guidance for CB-5083, highlighting its robust IC50 and translational potential in multiple myeloma and solid tumor research.
Carfilzomib (PR-171): A Translational Catalyst in ESCC Radio
2026-08-01
This thought-leadership article explores how Carfilzomib (PR-171), an irreversible proteasome inhibitor, is redefining strategies for overcoming radioresistance in esophageal squamous cell carcinoma (ESCC). Drawing on recent mechanistic insights and translational breakthroughs, we analyze its multi-modal induction of cell death, practical protocol considerations, and the future landscape for proteasome inhibition in cancer research. The discussion is grounded in both original research and advanced application strategies, positioning APExBIO Carfilzomib as a vital research tool for next-generation oncology.
459 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page